Published in
American Association for the Advancement of Science, Science Translational Medicine, 436(10), 2018
DOI: 10.1126/scitranslmed.aao5931
Links
Tools
Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer
Journal article published in 2018 by
Janos L. Tanyi 
,
Sara Bobisse,
Eran Ophir,
Sandra Tuyaerts ,
Annalisa Roberti ,
Raphael Genolet ,
Petra Baumgartner,
Brian J. Stevenson,
Christian Iseli ,
Denarda Dangaj,
Brian Czerniecki ,
Aikaterini Semilietof ,
Julien Racle ,
Alexandra Michel,
Ioannis Xenarios
and other authors.
,
Sara Bobisse,
Eran Ophir,
Sandra Tuyaerts ,
Annalisa Roberti ,
Raphael Genolet ,
Petra Baumgartner,
Brian J. Stevenson,
Christian Iseli ,
Denarda Dangaj,
Brian Czerniecki ,
Aikaterini Semilietof ,
Julien Racle ,
Alexandra Michel,
Ioannis Xenarios
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
Personalized cancer vaccines induce antitumor T cells that correlate with clinical benefit in patients with ovarian cancer.